Drawing for CIRECA

USPTO serial 87505089

CIRECA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MACFARLANE, JAMES W
Law office
DIVISIONAL UNIT

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CIRECA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael J. Zinna

MICHAEL J. ZINNA KELLEY DRYE & WARREN LLPONE JEFFERSON ROADPARSIPPANY, NJ 07054UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009X-ray energy dispersive spectroscopy software for qualitative and quantitative analysis; downloadable anatomic pathology software that assists pathology labs in organizing data, managing workflow, and generating reports for clients and internal use; computer software for use with mobile and handheld electronic devices in automated acquisition and analysis of images of human cells and tissues for pathology; electronic spectral databases in the field of pathology recorded on computer media; downloadable spectral databases in the field of pathology and the use of biomarkers for disease detection and treatment; and downloadable electronic publications, namely, pathology reports in the field of gene therapy design and delivery; electronic publications, namely, pathology reports in the field of gene therapy design and delivery recorded on computer mediaACTIVE—
010Medical devices, namely, microscopes and spectrometers, infrared microscopes, infrared fiber-optics and infrared probes for performing tests in the field of biomarkers for disease detection and treatment delivery and treatment decision makingACTIVE—
035Data management for others of patient sample databases consisting of patient biomarker samplesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 21, 2019NOACCORRECTED NOA E-MAILED—
Feb 20, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 20, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 20, 2019DPCCDIVISIONAL PROCESSING COMPLETE—
Feb 20, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 23, 2019DRRRDIVISIONAL REQUEST RECEIVED—
Jan 23, 2019ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Jul 24, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 20, 2018EX1GSOU EXTENSION 1 GRANTED—
Jul 20, 2018EXT1SOU EXTENSION 1 FILED—
Jul 20, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 23, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 28, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 28, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 8, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 26, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 20, 2017ALIEASSIGNED TO LIE—
Oct 6, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 29, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Sep 29, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 29, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 29, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 22, 2017DOCKASSIGNED TO EXAMINER—
Jul 4, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 1, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 29, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance